{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2006-N-0304\" sorted by posted_date descending", "rows": [["FDA-2006-N-0304-0051", "FDA", "FDA-2006-N-0304", "Use of Ozone-Depleting Substances: Removal of Essential-Use Designation (Flunisolide, etc.); Correction", "Notice", "NCR-Notice of Correction", "2010-09-17T04:00:00Z", 2010, 9, "2010-09-17T04:00:00Z", null, "2011-06-11T16:25:59Z", "2010-23195", 0, 0, "0900006480b51d24"], ["FDA-2006-N-0304-0050", "FDA", "FDA-2006-N-0304", "OMB Changes, Executive Order 12866 (E.O.) [Use of Ozone-Depleting Substances; Removal of Essential-Use Designations (Flunisolide, etc.)] - Reference", "Other", "REF-Reference Material (internal attachments)", "2010-04-27T04:00:00Z", 2010, 4, "2010-04-27T04:00:00Z", null, "2013-07-27T23:17:05Z", null, 0, 0, "0900006480ae1652"], ["FDA-2006-N-0304-0045", "FDA", "FDA-2006-N-0304", "Reference 07  - U.S. Environmental Protection Agency. \"The Benefits and Costs of the Clean Air Act: 1990-2010\" [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:50:58Z", null, 0, 0, "0900006480ad651c"], ["FDA-2006-N-0304-0040", "FDA", "FDA-2006-N-0304", "List  of References - [FDA-2006-N-0304 Notice of Final Rule 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:50:50Z", null, 0, 0, "0900006480ad5ea8"], ["FDA-2006-N-0304-0044", "FDA", "FDA-2006-N-0304", "Reference 06 - United Nations Environmental Programme, Production and Consumption of Ozone-Depleting Substances: 1986-2004, 2005. [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:50:56Z", null, 0, 0, "0900006480ad651b"], ["FDA-2006-N-0304-0043", "FDA", "FDA-2006-N-0304", "Reference 04 - Envrios March, Study on the Use of HFCs for Metered Dose Inhalers In the European Union: Final report following submission to the ECCP (European Commission Climate Change Policy Group)  [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:50:55Z", null, 0, 0, "0900006480ad5eac"], ["FDA-2006-N-0304-0042", "FDA", "FDA-2006-N-0304", "Reference 03 - US Department of Commerce, Census Bureau; Economics and Statistics Administration, Pharmaceutical Preparation Manufacturing: 2002 [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:50:53Z", null, 0, 0, "0900006480ad5eab"], ["FDA-2006-N-0304-0049", "FDA", "FDA-2006-N-0304", "Reference 15 -  DeNavas-Walt, C. B. D. Proctor, and J. C Smith, U.S. Census Bureau, Current Population Reports, P60-236(RV), Income, Poverty, and Health Insurance Coverage in the United States: 2008, Table 7, p. 21. 2009 [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:51:03Z", null, 0, 0, "0900006480ad6348"], ["FDA-2006-N-0304-0046", "FDA", "FDA-2006-N-0304", "Reference 08 - American Lung Association, \"Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality,\" [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:50:59Z", null, 0, 0, "0900006480ad651d"], ["FDA-2006-N-0304-0039", "FDA", "FDA-2006-N-0304", "Use of Ozone-Depleting Substances; Removal of Essential-Use Designation: Flunisolide, etc.", "Rule", "NFR-Notice of Final Rule", "2010-04-14T04:00:00Z", 2010, 4, "2010-04-14T04:00:00Z", null, "2011-06-11T16:25:59Z", "2010-08467", 0, 0, "0900006480ad7218"], ["FDA-2006-N-0304-0041", "FDA", "FDA-2006-N-0304", "Reference 01 - Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR-3), NIH Publication No. 07-4051 [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:50:52Z", null, 0, 0, "0900006480ad5ea9"], ["FDA-2006-N-0304-0047", "FDA", "FDA-2006-N-0304", "Reference 09 - American Lung Association, \"Trends in Asthma Morbidity and Mortality,\" January 2009 [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:51:01Z", null, 0, 0, "0900006480ad651e"], ["FDA-2006-N-0304-0048", "FDA", "FDA-2006-N-0304", "Reference 11 - Analysis completed by FDA based on information provided by IMS Health,  [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010]", "Supporting & Related Material", "BKG-Background Material", "2010-04-14T04:00:00Z", 2010, 4, null, null, "2010-04-14T14:51:02Z", null, 0, 0, "0900006480ad6572"], ["FDA-2006-N-0304-0038", "FDA", "FDA-2006-N-0304", "Graceway Pharmaceuticals, LLC - Supplement Comment re FDA-2006-N-0304-0032", "Other", "SUP-Supplement", "2010-02-03T05:00:00Z", 2010, 2, "2010-02-03T05:00:00Z", null, "2013-07-27T23:05:37Z", null, 0, 0, "0900006480a8731b"], ["FDA-2006-N-0304-0031", "FDA", "FDA-2006-N-0304", "Use of Ozone-Depleting Substances; Removal of Essential-Use Designations; Extension of Comment Period [re FDA-2006-N-0304-0005 and FDA-2006-N-0304-0001]", "Notice", "NEC-Notice of Extension", "2009-05-29T04:00:00Z", 2009, 5, "2009-05-29T04:00:00Z", null, "2009-06-30T18:48:45Z", null, 0, 0, "09000064809bf51d"], ["FDA-2006-N-0304-0028", "FDA", "FDA-2006-N-0304", "Background Information - American Lung Association, Trends in Asthma Morbidity and Mortality, Epidemiology & Statistics Unit, Research and Program Services, July 2006.", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:26:08Z", null, 0, 0, "09000064804593a8"], ["FDA-2006-N-0304-0024", "FDA", "FDA-2006-N-0304", "Background Information - National Heart, Lung, and Blood Institute, Expert Panel Report: Update on Selected Topics 2002: Guidelines for the Diagnosis and Management of Asthma, NIH publication No. 02-5074, June 2003 [Article continues in FDA-2006-N-0304-0025]", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:36:51Z", null, 0, 0, "090000648045939c"], ["FDA-2006-N-0304-0016", "FDA", "FDA-2006-N-0304", "Background Information - Reference: Analysis completed by FDA based on information provided by IMS Health, IMS National Sales Perspective (TM), 2005, extracted March 2006. These data are available for purchase from IMS Health. Please send all inquiries to: IMS Health, Attn: Brian Palumbo, Account Manager, 660 West Germantown Pike, Plymouth Meeting, PA 19462", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:25:54Z", null, 0, 0, "0900006480459369"], ["FDA-2006-N-0304-0020", "FDA", "FDA-2006-N-0304", "Background Information - Reference: \"Surveillance for Asthma \u2014 United States, 1980\u20131999 -- Malaria Surveillance \u2014 United States, 1999,\" MMWR Morbidity andMortality  Weekly Report, 2002", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:25:59Z", null, 0, 0, "0900006480459377"], ["FDA-2006-N-0304-0023", "FDA", "FDA-2006-N-0304", "Background Information - References", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:26:02Z", null, 0, 0, "0900006480459387"], ["FDA-2006-N-0304-0022", "FDA", "FDA-2006-N-0304", "Background Information - National Heart, Lung, and Blood Institute, Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma, NIH publication No. 97-4051, July 1997 - Continued [Article begins in FDA-2006-N-0304-0027]", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:35:31Z", null, 0, 0, "0900006480459385"], ["FDA-2006-N-0304-0027", "FDA", "FDA-2006-N-0304", "Background Information - National Heart, Lung, and Blood Institute, Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma, NIH publication No. 97-4051, July 1997 (continued in FDA-2006-N-0304-0022)", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:33:28Z", null, 0, 0, "09000064804593a5"], ["FDA-2006-N-0304-0026", "FDA", "FDA-2006-N-0304", "Background Information - United Nations Environmental Programme, Production and Consumption of Ozone-Depleting Substances: 1986-2004, 2005", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:26:06Z", null, 0, 0, "09000064804593a3"], ["FDA-2006-N-0304-0025", "FDA", "FDA-2006-N-0304", "Background Information - National Heart, Lung, and Blood Institute, Expert Panel Report: Update on Selected Topics 2002: Guidelines for the Diagnosis and Management of Asthma, NIH publication No. 02-5074, June 2003 - continued", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:26:05Z", null, 0, 0, "090000648045939f"], ["FDA-2006-N-0304-0017", "FDA", "FDA-2006-N-0304", "Background Information - Reference: Rozek, R.P., and E.R. Bishko, Economics Issues Raised in the FDA's Proposed Rule on Removingthe Essential-Use Designation for Albuterol MDIs, National Economic Research Associates, August 13, 2004 (FDA Docket No. 2003P-0029 C 25)", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:25:55Z", null, 0, 0, "090000648045936a"], ["FDA-2006-N-0304-0019", "FDA", "FDA-2006-N-0304", "Background Information - Reference: U.S. Environmental Protection Agency, The Benefits and Costs of the Clean nAir Act: 1990-2010. (http://www.epa.gov/air/sect812/copy99.html) (November 1999).", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:25:57Z", null, 0, 0, "0900006480459373"], ["FDA-2006-N-0304-0021", "FDA", "FDA-2006-N-0304", "Background Information - Reference: DeNavas-Walt, C., B.D. Proctor, and C.H. Lee, U.S. Census Bureau, Current Population Reports, P60-229, Income, Poverty, and Health Insurance Coverage in the United States: 2004, p. 18, 2005", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:26:00Z", null, 0, 0, "0900006480459378"], ["FDA-2006-N-0304-0018", "FDA", "FDA-2006-N-0304", "Background Information - Reference: \"Chronic Obstructive Pulmonary Disease Surveillance \u2014 United States, 1971\u20132000\" MMWR Morbidity and Mortality Weekly Report, CDC", "Supporting & Related Material", "BKG-Background Material", "2008-12-08T05:00:00Z", 2008, 12, null, null, "2008-12-08T18:25:56Z", null, 0, 0, "0900006480459371"], ["FDA-2006-N-0304-0014", "FDA", "FDA-2006-N-0304", "Graceway Pharmaceuticals, LLC (Graceway) - Addendum to Comment", "Other", "AMD-Amendment", "2008-07-21T04:00:00Z", 2008, 7, "2008-07-21T04:00:00Z", null, "2008-12-09T19:09:49Z", null, 0, 0, "0900006480650364"], ["FDA-2006-N-0304-0015", "FDA", "FDA-2006-N-0304", "Abbott - Withdrawal", "Other", "WDL-Withdrawal", "2008-07-21T04:00:00Z", 2008, 7, "2008-07-21T04:00:00Z", null, "2013-07-27T22:18:53Z", null, 0, 0, "0900006480680030"], ["FDA-2006-N-0304-0012", "FDA", "FDA-2006-N-0304", "Graceway Pharmaceuticals, LLC - Request for Extension of Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2008-07-21T04:00:00Z", 2008, 7, "2008-07-21T04:00:00Z", null, "2013-07-27T20:44:31Z", null, 0, 0, "09000064804593ad"], ["FDA-2006-N-0304-0013", "FDA", "FDA-2006-N-0304", "Graceway Pharmaceuticals - Request for Extension of Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2008-07-21T04:00:00Z", 2008, 7, "2008-07-21T04:00:00Z", null, "2013-07-27T20:44:31Z", null, 0, 0, "09000064804593bc"], ["FDA-2006-N-0304-0009", "FDA", "FDA-2006-N-0304", "University of Alabama at Birmingahm (UAB) - Letter", "Other", "LET-Letter", "2008-06-02T04:00:00Z", 2008, 6, "2008-06-02T04:00:00Z", null, "2008-06-03T00:17:05Z", null, 0, 0, "09000064804593b9"], ["FDA-2006-N-0304-0010", "FDA", "FDA-2006-N-0304", "Lisa Delaney Correspondence to the Center for Drug Evaluation and Research - Electronic Letter", "Other", "ELET-Electronic Letter", "2008-06-02T04:00:00Z", 2008, 6, "2008-06-02T04:00:00Z", null, "2008-06-03T00:17:06Z", null, 0, 0, "090000648045aaf8"], ["FDA-2006-N-0304-0002", "FDA", "FDA-2006-N-0304", "See FDA-2006-N-0304-0030", "Supporting & Related Material", null, "2007-09-26T00:00:00Z", 2007, 9, null, null, "2009-03-11T19:34:10Z", null, 0, 1, "090000648045b7c1"], ["FDA-2006-N-0304-0005", "FDA", "FDA-2006-N-0304", "Use of Ozone-Depleting Substances; Removal of Essential-Use Designations; Extension of Comment Period", "Notice", "NEC-Notice of Extension", "2007-08-07T04:00:00Z", 2007, 8, "2007-08-06T04:00:00Z", "2007-09-11T03:59:59Z", "2009-05-29T18:06:16Z", null, 0, 0, "09000064804597f1"], ["FDA-2006-N-0304-0004", "FDA", "FDA-2006-N-0304", "Use of Ozone-Depleting Substances; Removal of Essential-Use Designations; Public Meeting", "Notice", "NM-Notice of Meeting", "2007-07-09T04:00:00Z", 2007, 7, "2007-07-06T04:00:00Z", null, "2008-06-03T00:07:41Z", null, 0, 0, "09000064804593af"], ["FDA-2006-N-0304-0001", "FDA", "FDA-2006-N-0304", "Use of Ozone-Depleting Substances; Removal of Essential-Use Designations", "Proposed Rule", "NPR-Notice of Proposed Rule-Making", "2007-06-06T04:00:00Z", 2007, 6, "2007-06-06T04:00:00Z", "2007-08-11T03:59:59Z", "2008-12-08T18:38:09Z", null, 0, 0, "09000064804592b2"], ["FDA-2006-N-0304-0006", "FDA", "FDA-2006-N-0304", "Environmental Assessment [FDA-2006-N-0304-0001]", "Supporting & Related Material", "EA-Environmental Assessment", "2007-06-06T04:00:00Z", 2007, 6, null, null, "2008-06-03T00:14:44Z", null, 0, 0, "090000648045935f"], ["FDA-2006-N-0304-0008", "FDA", "FDA-2006-N-0304", "Findings of No Significant Impact [FDA-2006-N-0304-0001]", "Supporting & Related Material", "FONS-Finding of no Significant Impact", "2007-06-06T04:00:00Z", 2007, 6, null, null, "2008-06-03T00:16:19Z", null, 0, 0, "0900006480459367"]], "truncated": false, "filtered_table_rows_count": 40, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2006-N-0304"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304", "results": [{"value": "FDA", "label": "FDA", "count": 40, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2006-N-0304", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 26, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&document_type=Notice", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304", "results": [{"value": 2008, "label": 2008, "count": 19, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&posted_year=2008", "selected": false}, {"value": 2010, "label": 2010, "count": 14, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&posted_year=2010", "selected": false}, {"value": 2007, "label": 2007, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&posted_year=2007", "selected": false}, {"value": 2009, "label": 2009, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&posted_year=2009", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&_facet=comment_start_date"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2006-N-0304&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 771.1568570230156, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}